Aurora Cannabis Inc. closed 29.30% below its 52-week high of $9.35, which the company reached on April 30th.

Aurora Cannabis (ACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Aurora Cannabis Inc (ACB) reports a robust quarter with significant increases in global medical cannabis revenue and a ...

Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.

As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...

Tilray, Aurora Cannabis, Canopy Growth, Turning Point Brands, and Innovative Industrial Properties are the five Cannabis stocks to watch today, according to MarketBeat’s stock screener tool. Cannabis ...

Greetings and welcome to the Aurora Cannabis Inc. Third Quarter 2025 Results Conference Call. All participants will be in a listen-only mode and a question-and-answer session will follow the formal ...

Roth Capital issued their Q1 2026 EPS estimates for shares of Aurora Cannabis in a report released on Thursday, February 6th.

Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to loss of $0.20 per share a year ago.

CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical ...

Shares of Aurora Cannabis Inc. ACB rose 6.36% to $3.68 Tuesday, on what proved to be an all-around positive trading session ...

(1) Working capital for the three months ended December 31, 2024 has been adjusted. Refer to discussion under "Liquidity and Capital Resources" section of the MD&A. View original content to ...